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Abstract: 
 
Objective: 
Abnormally low flow conditions, sensed by the arterial endothelium, promote 
aneurysm rupture. Fibronectin (FN) is among the most abundant extracellular 
matrix proteins and is strongly upregulated in human aneurysms, suggesting a 
possible role in disease progression. Altered FN splicing can result in the 
inclusion of EIIIA and EIIIB exons, generally not expressed in adult tissues. We 
wished to explore the regulation of FN and its splicing and their possible roles in 
the vascular response to disturbed flow. 
 
Approach and Results: 
We induced low and reversing flow in mice by partial carotid ligation, and 
assayed FN splicing in an endothelium-enriched intimal preparation. Inclusion of 
EIIIA and EIIIB was increased as early as 48hrs, with negligible increases in total 
FN expression. To test the function of EIIIA and EIIIB inclusion, we induced 
disturbed flow in EIIIAB-/- mice unable to include these exons and found that 
they developed focal lesions with hemorrhage and hypertrophy of the vessel wall. 
Acute deletion of floxed FN caused similar defects in response to disturbed flow, 
consistent with a requirement for the upregulation of the spliced isoforms, rather 
than a developmental defect. Recruited macrophages promote FN splicing, since 
their depletion by clodronate liposomes blocked the increase in endothelial EIIIA 
and EIIIB inclusion in the carotid model.  
  
Conclusions: 
These results uncover a protective mechanism in the inflamed intima that 
develops under disturbed flow, by showing that splicing of FN mRNA in the 
endothelium, induced by macrophages, inhibits hemorrhage of the vessel wall. 
 
 
Introduction: 
 
Risk of aneurysm is determined globally by genetic defects and locally by 
hemodynamic effects. Genetic risk is often traced to defects in extracellular 
matrix proteins, such as fibrillin1, collagens, fibulin-4 and elastin in the case of 
thoracic aneurysm 1, and collagens in intracranial aneurysm and hemorrhagic 
stroke 2, 3. Other pathways, such as TGFβ and lysyl oxidase, are indirectly linked 
to extracellular matrix (ECM) protein deposition or organization. However, even 
given pre-existing genetic defects, not all blood vessels develop aneurysms; 
hemodynamics are a critical determinant of the location of aneurysms. For 
example intracranial aneurysms are more likely to grow and rupture in regions of 
the vasculature with disturbed flow 4, 5. The frictional force of flow, or shear 
stress, is sensed by the endothelium, which plays a critical role in regulating the 
vessels’ response to these flows 6. Thus, ECM composition and the endothelial 
response to disturbed flow are key determinants of aneurysm progression. 
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Fibronectin (FN) is a principal component of the vascular ECM and is highly 
upregulated in human aneurysm 7-9. The assembly of FN is considered a crucial 
step towards the assembly of new vascular ECM, and essential for the matrix 
integration of many of the aforementioned aneurysm-linked proteins 10. FN 
production and deposition by the endothelium is increased in vitro by low and 
disturbed flow, and increased FN has been observed in areas of vasculature 
chronically exposed to disturbed flow 11. However, since FN deposition also 
appears to potently increase the pro-inflammatory signaling of overlying 
endothelial cells 11, 12 and play a prominent role in leukocyte recruitment in vivo 
13, the role of FN in vasculature exposed to low and disturbed flow is not yet 
clear. While its structural function might suggest protection, it could also promote 
pro-inflammatory signaling thought to drive aneurysm progression. Thus, while 
the role of FN in aneurysm is not yet clear, it is poised to be a major player in 
regulating disease progression. 
 
FN is alternatively spliced, resulting in variable inclusion of the EIIIA(EDA) and 
EIIIB(EDB) domains and portions of the variable (V or IIICS) domain 9, 14. Among 
vertebrates, EIIIA and EIIIB domains are as highly conserved at the amino acid 
level as other FN domains, suggesting strong evolutionary pressure 15. Their 
expression patterns are conserved among all vertebrates examined, including 
human, mouse, rat, cow, chicken, frog and zebrafish, most prominently around 
the developing heart and blood vessels. Nearly complete inclusion during early 
development drops to <5-10% post-natally. Although adults express very little 
EIIIA or EIIIB, inclusion is increased in a variety of vascular injuries resulting in 
damage to the endothelium, such as balloon or wire injury in animal models 16-19. 
Increased inclusion of EIIIA and EIIIB has also been observed in human 
aneurysms 20. But how expression of EIIIA and EIIIB is regulated in aneurysm 
progression remains unclear. Also unclear is how the production of EIIIA+EIIIB+ 
FN affects vasculature damaged by expose to low and disturbed flow. 
 
We hypothesized that low and disturbed flow might promote the increased 
inclusion of alternative exons EIIIA and EIIIB in the arterial endothelium and, 
furthermore, that the upregulation of these alternative exons might play a role in 
preventing the destructive effects of low and disturbed flow on the arterial 
endothelium. Here we describe experiments supporting these hypotheses. 
 
 
Materials and Methods: 
 
Materials and Methods are available online. 
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Results: 
 
Low and disturbed arterial flow promotes increased inclusion of FN 
alternative exons, EIIIA and EIIIB. 
 
To examine alternative splicing in response to low and disturbed arterial flow, we 
performed near complete carotid ligation on C57BL/6J mice. This severely 
reduces mean blood velocity in the ligated carotid artery (by ~75%, Figure 1 & 4) 
and results in the pro-inflammatory activation of the endothelium 21. We collected 
RNA from the intima of these mice by a Trizol flush following published methods, 
yielding a 3000-fold enrichment of endothelial mRNA Pecam1 (CD31) relative to 
smooth muscle mRNA acta2 (alpha-smooth muscle actin) in the intimal 
preparation relative to the remainder of the carotid artery (Figure IA online) 21, 22. 
Purified intimal RNA was pooled from three groups of 4-5 vessels for each flow 
regime: low-flow (ligated) or high-flow (contralateral to the ligated artery). The 
mRNA pool was sequenced and splicing assessed by MISO 23. We found that, at 
48hrs, the levels of both EIIIA and EIIIB inclusion in the intima increased by 
about 3- to 4-fold over the levels in contralateral carotid intima (Figure 1A&B). 
Baseline levels of EIIIA inclusion (17%) were higher than EIIIB inclusion (5%), as 
were the levels under disturbed flow (55% for EIIIA and 19% for EIIIB). 
 
RNA-seq analysis provided an aggregate assessment of splicing changes in a 
large pool of mice. To determine splicing changes with greater resolution in the 
intima of individual carotid arteries, we established a quantitative PCR (qPCR) 
assay to measure fold changes in the levels of EIIIA+ and EIIIB+ mRNAs relative 
to total FN mRNA (Figure II online). We extrapolated the actual inclusion rates 
from the qPCR data, using cDNA prepared from sequenced samples to calibrate.  
 
Using these methods, we examined splicing in two more cohorts of mice, at 
48hrs and at 7 days after nearly complete carotid ligation. We found that the 
mean changes in inclusion observed by qPCR in these new cohorts replicated 
the results obtained by RNA-seq. Under low-flow conditions, EIIIA and EIIIB 
inclusion rates increased 2- to 3-fold (from 19% to 47% for EIIIA and from 5% to 
11% for EIIIB) over the high-flow contralateral carotid at 48hrs (Figure 1C). The 
high inclusion levels were maintained at the 7-day time-point (Figure 1D). We 
included sham-operated mice to control for splicing changes induced by the 
trauma of the surgery in the absence of flow changes. Although surgery alone 
induced a slight increase in EIIIA and EIIIB inclusion at 48hrs, this was less than 
the change induced by low and disturbed flow [compare Ligated Low(L) vs. 
Sham noΔ(L) at 48hrs], and the effect disappeared by 7 days. Interestingly, the 
change in splicing occurred without a significant change in the total FN 
expression at either 48hrs or 7 days (Figure 1E&F). Thus, low and disturbed flow 
acutely increases intimal EIIIA and EIIIB inclusion, as measured by two 
independent techniques, and this occurs without significant increases in total FN 
expression. 
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We then asked whether similar changes occurred in the media and adventitia, or 
whether they were confined to the intima. We used the same qPCR approach, 
except that analysis was performed on the remainder of the carotid artery, after 
the intimal flush. We found that, in contrast to the intimal changes, there were no 
significant differences in splicing between ligated and sham-operated arteries at 
48hrs (Figure IIIA online). After exposure to 7 days of low and disturbed flow, 
inclusion of both EIIIA and EIIIB were increased around 2-fold in the media & 
adventitia relative to the sham-operated carotid (Figure IIIC online). So, EIIIA and 
EIIIB inclusion is also increased in the carotid media & adventitia by low and 
disturbed flow, but the magnitude of the switch is significantly lower relative to 
that in the intima. There were no differences in total FN expression (Figure 
IIIB&D online). 
 
Although enriched for endothelium, the intimal flush includes RNA from adherent 
leukocytes, as well as fibroblasts and smooth muscle cells. To confirm that the 
alternatively spliced FN transcripts in the intima were endothelium-derived, we 
used Cdh5-CreERT2 to excise floxed FN in the endothelium prior to disturbing 
flow (Figure IB online). Total FN expression was reduced ~90% in the intima at 7 
days, without a significant reduction in the media & adventitia. Similarly, there 
was a ~90% reduction in EIIIA and EIIIB (Figure IC online). These results 
indicate that the endothelium is the primary source of alternatively spliced FN in 
the intimal response to altered shear. 
 
Absence of EIIIA and EIIIB inclusion promotes hemorrhage of the vessel 
wall in response to low and disturbed flow. 
 
To test the function of EIIIA and EIIIB inclusion in the vascular response to low 
flow, we performed carotid ligation in EIIIA-/-; EIIIB-/- (EIIIAB-/-) mice unable to 
include EIIIA and EIIIB 24. After 7 days of low flow, carotid arteries of EIIIAB-/- 
mice showed localized hemorrhage of the vessel wall, typically associated with 
bulges in the artery (Figure 2A). To quantify these differences further, excised 
vessels were scored for an “injury” phenotype based on the degree of 
hemorrhage and/or bulging of the wall (Figure IV online). To confirm the 
presence of blood beneath the intimal endothelial cell layer, we performed 
immunofluorescence staining for the endothelial cell marker Pecam1 (CD31) and 
the erythrocyte marker Ter119. We found large areas of Ter119-labeled blood 
cells beneath the CD31-labeled endothelium, confirming that blood had leaked 
into the vessel wall and beneath the endothelium (Figure 2B and Figure V 
online). Although hemorrhages also occurred in the wild-type littermate controls, 
they were much less frequent (14% vs. 47%, P=0.02, Fisher’s exact test). 
Importantly, we observed no differences in the level of flow reduction induced by 
carotid ligation in EIIIAB-/- and EIIIAB+/+ mice, indicating that the inability to 
alternatively splice FN is the underlying cause of the hemorrhages, rather than a 
quantitative difference in the hemodynamic stimulus (Figure 2C). 
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Histological analysis of the arteries suggests that a local expansion of the 
adventitia may contribute to the appearance of the bulged regions, since 
significant differences could be observed in thickness of the adventitia across 
multiple regions of EIIIAB-/- arteries versus EIIIAB+/+ or EIIIAB+/- arteries 
(Figure VI online). In addition to the localized expansion of the adventitia, we also 
observed focal dilation of the artery lumen in vivo, by high-resolution ultrasound 
images collected at the 7 day endpoint. These focal dilations resulted in regions 
30-70% larger than adjacent sections of the same artery, and could be observed 
in 5/9 arteries with hemorrhage, and 2/9 arteries without obvious hemorrhage. 
Similar focal dilations did also occur in ligated EIIIAB+/+ control arteries, but the 
frequency was lower (8/26) overall, and followed a similar trend – appearing 
more often in arteries with hemorrhage (Figure VII online). Thus, hemorrhage 
was associated with both increased adventitial growth and lumen enlargement. 
 
Based on proximity of the hemorrhage to the intimal layer, the severe damage to 
the VE-cadherin-labeled endothelial layer, and the ingrowth of VE-cadherin+ 
vessels from the intima into the vessel wall in vessels with bleeds 
(Supplementary Movie 1 and 2), we believe that these bleeds originate from the 
carotid lumen, rather than from the vasa vasorum. Hemorrhage and bulges were 
specific to the low-flow carotid artery, and never observed in sham-operated 
vessels (N=11) or contralateral arteries (N=110). Extravascular bleeding 
occurred at some point between 48hrs and 7 days, since it was never observed 
in any vessels harvested at 48hrs, including EIIIAB-/- (N=5) and a variety of other 
genotypes (N=101). Therefore, in mice unable to include alternative FN exons 
EIIIA and EIIIB, the intima is at increased risk of hemorrhage and injury when 
chronically exposed to low and disturbed flow. Notably, the most injured arteries 
had some of the highest inclusion levels recorded (Figure 1, colored points). 
Interestingly, this was specific to the intima, changes in medial splicing were not 
associated with the severity of the phenotype (Figure III online).  
 
To determine whether the flow-induced hemorrhage could be linked to one of the 
two alternatively spliced domains, we examined EIIIA-/- mice unable to include 
EIIIA 18. These mice appeared to show a milder form of the vessel wall 
hemorrhage phenotype (Figure IV online) and also showed instances of bleeding 
beneath the endothelium (Figure VIII online). Thus, the inability to include one of 
the two alternatively spliced exons may also increase the risk of hemorrhage, but 
with lower penetrance. 
 
Since the hemorrhage and injury we observed resemble aspects of dissecting 
aneurysms, we tested whether the absence of EIIIA and EIIIB inclusion is 
increased in another model of aortic dissection, based on the systemic 
administration of a high-dose of angiotensin II (Ang-II) 25. In this model, Ang-II 
results in leukocyte recruitment, elastin degradation, medial apoptosis and 
partially penetrant dissection of the abdominal and thoracic aorta 26. Interestingly, 
despite abundant FN accumulation in the intima of Ang-II-treated mice, EIIIA and 
EIIIB inclusion was not increased to the same extent as in arteries exposed to 
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low and disturbed flow, nor were mice deficient in EIIIA and EIIIB at increased 
risk of abdominal aorta dissection in this model (Figure IX online). Thus, 
alternative FN splicing is more regulated and essential to the vascular response 
to low and disturbed flow than to Ang-II driven aortic dissection. 
 
Absence of EIIIA and EIIIB does not inhibit FN expression or deposition 
 
The development of vessel wall hemorrhage in EIIIAB-/- mice led us to question 
whether the absence of EIIIA and EIIIB resulted in reduced FN expression or 
deposition. We examined constitutive FN mRNA in the intimal flush and in the 
remaining media & adventitia of EIIIAB-/- mice and littermate controls subjected 
to nearly complete carotid ligation. We found that there was no difference in the 
level of total FN mRNA in the intima at 7 days after nearly complete carotid 
ligation in EIIIAB-/- mice relative to their littermate controls (Figure 3A). So, the 
absence of EIIIA and EIIIB did not impinge on the levels of FN transcript in either 
the intima or the media & adventitia. 
 
At the protein level, results were similar. Increased FN deposition could be 
observed in the intima of ligated carotid arteries, relative to sham-operated 
controls, but the level of staining was not significantly reduced in EIIIAB-/- mice 
(Figure 3B). Instead, there was increased deposition of FN in the intima of 
EIIIAB-/- mice, as determined by quantitative immunofluorescence (Figure 3C). 
Although all mice that developed vessel wall hemorrhage had high levels of 
intimal FN, only in the EIIIAB-/- group was FN deposition increased in the 
absence of severe injury (score ≥2). It is not yet clear whether the increased FN 
deposition represents leak of plasma FN; extravasation of plasma albumin was 
not significantly increased by the same methods, although it was increased 
relative to the contralateral artery (Figure X online). 
 
Acute deletion of FN promotes hemorrhage of the vessel wall in response 
to low and disturbed flow 
 
Hemorrhage in response to low and disturbed flow could be a consequence of 
the absence of the EIIIA and EIIIB isoforms throughout vascular development, 
the inability to increase the expression of these isoforms under low and disturbed 
flow, or both. To tease apart these possibilities, we investigated whether there 
was an acute requirement for FN expression in the response to low and 
disturbed flow. We had previously observed that the acute deletion of floxed FN 
in the endothelium by Cdh5-CreERT2 almost entirely ablated endothelial FN 
mRNA (Figure I online), but did not predispose to flow-induced hemorrhage 
(Figure 4 and Figure IV online). However, our analysis of FN splicing had 
revealed increased EIIIA+EIIIB+ FN mRNA in the adjacent media following 
carotid ligation (Figure IIIC online), suggesting that smooth muscle cells may be 
compensating for endothelial FN production. Further supporting this line of 
reasoning, there was a trend towards increased expression of EIIIA+ and EIIIB+ 
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FN in the media & adventitia of Cdh5-CreERT2; FNf/f mice subjected to nearly 
complete carotid ligation (Figure IC online).  
 
To determine whether FN production by mural cells is able to compensate for the 
acute deletion of FN in the endothelium we took two complementary approaches, 
using Rosa26-CreERT2; FNf/f mice to delete FN acutely and globally <1 week 
before carotid ligation, and a combination of SM22-Cre and Cdh5-CreERT2 to 
acutely delete endothelial FN <1 week before carotid ligation in the absence of 
smooth muscle FN.  
 
As expected, Rosa26-CreERT2 effectively activated a Cre reporter throughout 
most, but not all, of the endothelial and smooth muscle cells (Figure 4) and 
ablated plasma FN within 2 days (data not shown), resulting in a nearly complete 
inhibition of FN protein deposition in the intima of vessels exposed to low and 
disturbed flow (Figure 4). Without the ability to acutely increase FN production, 
arteries were susceptible to hemorrhage (2/8 mice and none of the littermate 
controls) and almost all of the arteries demonstrated a failure in inward 
remodeling (Figure 4, Figure IV and VII online). In fact, the lumen of many of the 
arteries enlarged beyond the size of sham-operated controls (Figure VII online). 
Importantly, neither injury nor hemorrhage were observed in the contralateral 
arteries or sham-operated Rosa26-CreERT2; FNf/f arteries, indicating that 
enlargement of the artery and hemorrhage were specifically induced by low and 
disturbed flow conditions, rather than by the acute ablation of FN expression. 
 
However, Rosa26-CreERT2 removes all sources of FN production, including 
EIIIA-EIIIB- plasma FN. To address more specifically the acute requirement for 
the EIIIA+ and EIIIB+ FN variants produced by the endothelium, and to delete FN 
more stringently in the vessel wall, we examined Cdh5-CreERT2; SM22-Cre; FNf/f 
mice after the acute deletion of endothelial FN (<1 week prior to nearly complete 
carotid ligation). SM22-Cre allowed stronger deletion of FN in the vessel wall 
than Rosa26-CreERT2, and Cdh5-CreERT2 was more effective in the deletion of 
endothelial FN than Rosa26-CreERT2. Despite abundant FN, presumably 
plasma-derived and EIIIA-EIIIB-, in the intima, arteries unable to produce EIIIA+ 
and EIIIB+ FN variants in the endothelium developed hemorrhage. Importantly, 
none of these defects was observed in SM22-Cre; FNf/f littermates, which were 
born in Mendelian ratios without noticeable vascular defects (Figure 4 and Figure 
IV online) and resembled littermate FNf/f mice in carotid structure and response to 
low and disturbed flow, indicating that the defects observed were a result of the 
absence of endothelial FN. 
 
Therefore, both approaches that acutely blocked the ability to produce new 
endothelial EIIIA+EIIIB+ FN replicated the hemorrhages in the vessel wall 
observed in EIIIAB-/- mice. Notably, of the two approaches, a stronger phenotype 
was observed using Cdh5-CreERT2; SM22-Cre; FNf/f than Rosa26-CreERT2, 
despite the presence of abundant remaining plasma FN in the former case. 
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Macrophages are required for the induction of EIIIA and EIIIB in the vessel 
wall. 
 
Given the importance of the endothelial FN splicing switch in preventing the 
damaging effects of disturbed blood flow on the vessel wall, we investigated how 
the splicing switch is regulated. We found that macrophages, which are often 
recruited to sites of injury where EIIIA and EIIIB expression is increased, are 
recruited to the carotid arterial endothelium under disturbed flow conditions 
(Figure XI online). Therefore, we hypothesized that they might promote EIIIA and 
EIIIB inclusion.  
 
To test this, we used clodronate liposomes to deplete macrophages in mice 
subjected to carotid ligation, and examined EIIIA and EIIIB expression in the 
intimal flush. Analysis of the macrophage-specific mRNA Cd68 revealed that the 
7-fold increase induced by low and disturbed flow conditions could be completely 
blocked by clodronate-liposome treatment (Figure 5A). Inhibiting the recruitment 
of macrophages resulted in a suppression of increased FN expression (Figure 
5B) and a complete abrogation of the induction of EIIIA and EIIIB by low and 
disturbed flow (Figure 5C&D). Therefore, the switch in endothelial splicing under 
low and disturbed flow depends on macrophages, which are recruited in large 
numbers under these conditions.   
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Discussion: 
 
Low and disturbed arterial flow is known to promote aneurysm growth and 
rupture 5, 27. The ECM is profoundly altered in late-stage aneurysms, but how 
disturbed flow regulates ECM composition in vivo remains poorly characterized. 
Furthermore, how acute changes in individual ECM components during 
aneurysm formation might contribute to or inhibit further progression is unclear. 
Here, we show that macrophages, recruited by disturbed flow 28, promote a rapid 
change in FN splicing resulting in increased expression of EIIIA+ and EIIIB+ 
variants as early as 48hrs after a change in flow. The acute upregulation of these 
isoforms inhibits hemorrhage of the vessel wall, revealing a protective splicing 
mechanism in the vascular endothelium of regions exposed to severely disturbed 
flow. 
  
Upregulation of alternative splice variants of FN protects against 
hemorrhage of the vessel wall under low and disturbed flow. 
 
 Our results suggest that alternative FN splicing in the vessel wall is an 
important protective mechanism against hemorrhagic rupture of the intima, and 
therefore may play a role in the growth and rupture of areas of aneurysm 
exposed to disturbed flow. Increased EIIIA and EIIIB inclusion has been 
observed in late-stage human aortic aneurysms 20. Interestingly, EIIIA failed to 
increase in a subgroup of patients at higher risk of dissecting aneurysm 20. The 
same patient group (bicuspid aortic valve) is also at increased risk of intracranial 
aneurysm, although it is not clear whether this is due to altered FN splicing 29. 
Given the phenotypic complexity of human samples, these observations 
remained correlative. Here, we provide genetic evidence that deficient EIIIA and 
EIIIB inclusion directly increases the risk of damage to the vessel wall. 
 
 It is not clear why deficiency in EIIIA and EIIIB inclusion promotes 
hemorrhage in response to disturbed flow but not in response to Ang-II. Perhaps 
one clue lies in the cell types most affected. Low and disturbed flow acts primarily 
on the endothelium. In the carotid ligation model, macrophage accumulation and 
changes in FN splicing were strongest in the intima. In contrast, it has been 
proposed that macrophages recruited to the adventitia drive aortic dissection in 
the Ang-II model 30. Our data show that both macrophage recruitment and 
alternative FN splicing are reduced in the Ang-II intima, relative to the intima of 
vessels exposed to low and disturbed flow. Thus, we suggest that alternative FN 
splicing will be of greatest importance in preventing vascular damage in diseases 
with a strong component of endothelial activation and inflammation. 
 
 The mechanisms of protection conferred by EIIIA and EIIIB are of 
considerable interest. Several might be proposed: 1) EIIIA is known to bind and 
activate TLR4. This could skew macrophage phenotype directly, or affect the 
presentation of autoantigens from the lesion to innate immune cells (EIIIA has 
been shown to be a potent adjuvant, and immunization of mice with FN 
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decreases atherosclerotic vascular injury) 31, 32; 2) EIIIA inclusion in full-length 
recombinant FN has been shown to increase cell spreading in vitro suggesting 
that it may affect proliferation and apoptosis pathways linked to spreading 33; 3) 
Suppressing EIIIA and EIIIB inclusion in endothelial cells may affect 
fibrillogenesis 34, and thus both endothelial cell-cell junctions and permeability 35; 
4) Mice with increased EIIIA inclusion clot faster under arterial flow rates 36, 
suggesting that increasing EIIIA (and perhaps also EIIIB) inclusion may help 
quickly staunch intimal hemorrhage. A better understanding of how EIIIA and 
EIIIB prevent vessel damage should reveal new ways in which the vasculature 
locally resists flow-induced damage. 
 
 Macrophages promote the increased EIIIA and EIIIB inclusion in the 
endothelium 
 
We show that macrophage recruitment is critical for the increased 
expression of EIIIA and EIIIB. In a variety of other fibrotic injury settings, such as 
organ transplant rejection, and skin, lung, kidney and liver damage and cancer, 
EIIIA and EIIIB inclusion is increased 37. Among isolated cell types from the liver, 
endothelial cells showed the strongest increase in inclusion 38. This switch is 
thought to be one of the earliest steps in fibrosis, which is EIIIA-dependent in 
both lung and liver injury models 39, 40. Our data suggest that recruitment or 
activation of macrophages could provide signals to promote EIIIA inclusion. The 
specific mechanisms through which they induce FN splicing are not yet clear, but 
we have observed a good correlation between PAI1 and the inclusion of EIIIA 
and EIIIB, as well as total FN expression (Figure XII online), perhaps implicating 
TGFβ - known to regulate PAI1 and EIIIA inclusion in vitro 11. Conditional deletion 
of macrophages has revealed a critical role in driving fibrosis in the liver and the 
lung 41, 42. So, in a variety of fibrotic settings, macrophages may play a similar 
role in the induction of alternative FN splicing, with important implications for the 
composition and signaling of the fibrotic ECM. 
 
 Increased numbers of macrophages are found in ruptured intracranial 
aneurysms, and clodronate depletion experiments suggest macrophages drive 
the growth of intracranial aneurysms in elastase-induced animal models 43, 44. We 
observed that the chronic depletion of macrophages in our carotid ligation model 
acutely suppresses the flow-mediated activation of the endothelium (indicated by 
reduced intimal PAI-1 and α-Smooth muscle actin expression, Figure XIII online) 
and arterial stiffness (indicated by pulse distension, Figure XIII online), markers 
of arterial injury. Our current model (summarized in Figure XIV online) is that the 
exposure of the arterial endothelium to reduced blood flow increases the 
expression of leukocyte adhesion receptors (e.g., ICAM and VCAM), resulting in 
the recruitment of blood-derived monocytes to the intima. Monocytes differentiate 
to macrophages and elicit changes in the endothelium, including the alternative 
splicing of FN, that are critical in preventing damage to the vessel wall. Since 
macrophages are also instigators of arterial injury, alternative FN splicing in the 
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endothelium may be thought of as a mechanism induced by macrophages that 
protects against their own damaging effects on the vessel wall. 
 
Acute flow-induced hemorrhage of the vessel wall 
 
  Hemorrhage in the carotid artery under disturbed flow came as a surprise, 
since other investigators used the same model, and even inhibited FN assembly 
(using a small peptide inhibitor) but did not report vessel-wall hemorrhage 45-47. A 
likely explanation is that the penetrance of this phenotype on the wild-type 
background is low (4/27 AB+/+ littermate controls, 0/15 C57 mice +/- clodronate 
liposomes, 1/9 EIIIA+/- littermate controls, 0/22 FNf/f or FNf/+ littermate controls), 
and may have escaped the notice of previous investigators. In a typical cohort of 
5 to 10 mice, such defects would be rare. However, in the EIIIAB-/-, ROSA-
CreER; FNf/f and Cdh5-CreER; SM22-Cre; FNf/f mice, hemorrhage within the 
vessel wall was seen in higher numbers (9/19, 2/8 and 2/8 respectively) and thus 
was obvious. It is also possible that hemorrhage occurs acutely and is resolved 
by later, 2-3 week time points; we have not yet examined this in detail. 
Consistent with the idea that vessel-wall hemorrhage is a partially penetrant 
phenotype that can be exacerbated by genetic background, hemorrhage has 
been observed in the carotid plaques of ApoE-deficient mice subjected to nearly 
complete carotid ligation 21, 48. Similar to these ApoE-/- hemorrhages, we noted 
endothelial sprouting into the vessel wall 49 (Supplementary Movie 1 & 2). 
Interestingly, our en face imaging suggests that these sprouts originate from the 
lumen, rather than the vasa vasorum. Therefore, we suggest that the established 
carotid ligation model can be used as a platform to investigate the contributions 
of various genetic and epigenetic regulators of disturbed flow on intimal damage 
and hemorrhage of the vessel wall. 
 
 In conclusion, we report that the alternatively spliced EIIIA and EIIIB exons 
of FN, long-known to be conserved and highly regulated in all vertebrates but 
without clearly understood functions, play a significant role in protecting the 
vasculature from inflammation caused by disturbed flow. They are upregulated in 
response to disturbed flow by recruited macrophages, and if this upregulation is 
prevented, hemorrhagic injury of the vessel wall ensues. Since inclusion of these 
two domains of FN occurs in many pathological situations (atherosclerosis, 
myocardial infarction, organ transplant and other fibroses, angiogenesis and 
tumor progression), further investigation of the regulation and function of FN 
splicing is warranted. An emerging view is that alternative-splicing programs 
broadly regulate tissue function 50, 51. FN is likely only one of many genes 
affected by splicing changes in the activated vascular endothelium. Future work 
should aim to dissect the regulation and function of these splicing programs. 
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Significance: 
Brain aneurysms are fairly common, but their catastrophic rupture is not. 
Disturbed flow within the aneurysm is one of the best predictors of rupture, risk of 
which is strongly modified by extracellular matrix composition. Fibronectin (FN), 
an essential extracellular matrix protein, is abundant in human aneurysms where 
it is also alternatively spliced. However, neither the regulation of alternative FN 
splicing nor its impact on the vasculature have been clear.   
Here, we show that disturbed flow promotes alternative splicing of FN in 
the endothelium. Furthermore, we show that the splicing change is protective, 
since mutant mice unable to produce alternatively spliced FN are at increased 
risk of hemorrhage of the vessel wall. Mechanistically, we found that alternative 
FN splicing was almost entirely dependent on macrophages, recruited to the 
endothelium by disturbed flow. These results indicate that alternative FN splicing 
protects against the damaging effects of disturbed flow on the arterial wall. 
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Figure 1. Low and disturbed flow promotes inclusion of alternative exons 
EIIIA and EIIIB. 
A) Relative read densities in EIIIA, EIIIB and flanking exons from the sequenced 
intimal RNA of low-flow (ligated) and high-flow (contralateral) carotid arteries 
48hrs after surgery. Numbered curves indicate exon-spanning reads. B) Inclusive 
and exclusive reads were used by MISO to calculate the % inclusion rate (Psi) of 
alternative FN exons EIIIA and EIIIB. Average of three pools (4-5 arteries each) 
and the standard deviation is shown.  (C&D) Exon inclusion in individual carotid 
arteries as measured by quantitative PCR at 48hrs (C) and 7 days (D) after 
nearly complete carotid ligation or sham operation. (E&F) Fold-change in FN 
over sham-operated contralateral artery. Each dot (C-F) represents analysis of 
the intimal flush from a single carotid artery.  Significance of the difference 
between (B) low flow and high flow pools by Student’s t test and (C-F) the ligated 
left carotid measurements and the other groups by ANOVA and Tukey’s multiple 
comparison test : **P<0.01, ***P<0.001, ****P<0.0001. 
 
Figure 2. Mice deficient in EIIIA and EIIIB are prone to sub-endothelial 
hemorrhage in response to low and disturbed flow. 
A) Isolated carotid arteries from EIIIAB-/- and EIIIAB+/+ mice after 7 days of low 
and disturbed flow conditions.  Note the visible extravascular blood in the AB-/- 
mouse following saline perfusion (arrowheads). B) Combined staining for CD31 
and Ter119 shows blood cells beneath the endothelium.  Percent of mice with 
extravascular blood, following saline perfusion is shown in the graph. P=0.04 by 
two-tailed Fisher’s exact test. C) Mean ultrasound velocity from in vivo 
measurements at 7 days after nearly complete carotid ligation.  Each dot is the 
measurement of a single carotid artery.  Red dots indicate arteries with sub-
endothelial hemorrhage. Scale bars = 100µm and 25µm (higher magnification). 
 
Figure 3. Deficiency in EIIIA and EIIIB does not inhibit FN expression or 
deposition. 
A) Expression of FN mRNA in the intima and media/adventitia of AB+/+ and AB-
/- mice 7 days after ligation or sham operation.  Each dot represents analysis of 
the intimal flush from a single carotid artery. B) Immunofluorescence staining for 
total FN (red) and CD31 (green) in sections of carotid arteries, 7 days after 
ligation, with and without severe injury. C) Fluorescence intensity in sections of 
ligated carotid arteries in the intima or in the medial cell layers.  Each dot 
represents a single carotid artery.  **P<0.01 by two-tailed Student’s t test. Scale 
bars = 100µm 
 
Figure 4. Acute deletion of FN results in hemorrhage of the vessel wall. 
A) Excised vessels and sections of carotid artery from the indicated genotypes, 
showing expression of the mT/mG reporter (left panel) which switches from red 
to green upon Cre excision.  FN immunofluorescence staining of the same 
vessels is shown in the right panel. The ligations have been left on some vessels, 
to show their location distal to the site of the hemorrhages.  Arrowheads point to 
hemorrhage. B) Hematoxylin and eosin stained sections from the carotid arteries 
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shown above. Arrows point to blood beneath the endothelium (ROSA26-
CreERT2; FNf/f) and between elastin layers of the media (Cdh5-CreERT2; SM22-
Cre; FNf/f). Bottom right panel is immunofluorescence for CD31 (green), Ter-119 
(red) and DAPI (blue).  C) Mean ultrasound velocity from in vivo measurements 
at 7 days after nearly complete carotid ligation.  Each dot is the measurement of 
a single carotid artery.  Red dots indicate arteries with sub-endothelial 
hemorrhage, frequency of hemorrhage is indicated above. Scale bars = 100µm 
 
Figure 5. Endothelial EIIIA and EIIIB inclusion is increased in response to 
recruited macrophages 
A) Expression of CD68, a marker of macrophages, in the intimal RNA of 
C57BL/6J mice 48hrs after nearly complete carotid ligation, with or without prior 
treatment with chlodronate, as determined by quantitative PCR. B) Fold-change 
in FN expression, relative to the contralateral control from PBS liposome treated 
mice. C&D) Inclusion frequency of EIIIA (C) and EIIIB (D) in the intimal mRNA of 
the same C57BL/6J mice, as determined by quantitative PCR. (B-D). Each dot 
represents analysis of the intimal flush from a single carotid artery.  ANOVA and 
Tukey’s multiple comparison test **P<0.01, ***P<0.001. 
 	  
	  	  
Figure	  1.	  Primary	  tumor	  growth	  is	  not	  affected	  by	  the	  endothelial	  deletion	  of	  
alphaV	  and	  alpha5	  integrins.	  (A&B)	  Endothelial	  deletion	  of	  floxed	  alpha5	  integrin	  by	  Tie2-­‐Cre	  does	  not	  impair	  the	  growth	  of	  transplanted	  Lewis	  Lung	  (A)	  or	  B16	  melanoma	  tumors	  (B).	  	  (C&D)	  The	  deletion	  of	  both	  alphaV	  and	  alpha5	  by	  Cdh5-­‐CreERT2	  	  does	  not	  impair	  the	  growth	  of	  Lewis	  Lung	  transplant	  tumors	  (C)	  or	  RIP-­‐Tag2	  spontaneous	  pancreatic	  tumors	  (D).	  (E)	  Efficient	  excision	  of	  the	  host	  mT/mG	  Cre-­‐reporter	  by	  Chd5-­‐CreERT2	  in	  a	  transplanted	  Lewis	  Lung	  tumor.	  Note	  the	  close	  overlap	  of	  CD31	  with	  the	  eGFP	  Cre-­‐reporter.	  Red	  cells	  are	  host-­‐derived	  cells	  in	  the	  tumor	  without	  Cre-­‐excision.	  	  
NOTE:	  in	  these	  experiments	  host	  deletion	  (by	  Tam)	  was	  performed	  prior	  to	  
tumor	  growth.	  
NOTE:	  could	  show	  images	  of	  the	  same	  mT/mG	  reporter	  with	  the	  aV;a5	  
deletion	  in	  the	  experiment.	  
NOTE:	  should	  confirm	  the	  deletion	  in	  alphaV	  alpha5	  experiment	  	  -­‐ FACs	  of	  eGFP+	  tumor	  cells	  or	  aortic	  endothelial	  cells,	  qPCR	  for	  mRNA	  (aV,	  
a5,	  other	  integrins	  a4,	  a9	  in	  particular?)	  -­‐ IF	  for	  alpha5	  in	  tumor	  sections	  (alphaV	  is	  difficult)	  	   	  
	  
Figure	  2.	  Primary	  tumor	  growth	  is	  not	  affected	  by	  the	  host	  deletion	  of	  alphaV	  
and	  alpha5	  integrins.	  (A)	  Efficient	  excision	  of	  the	  host	  mT/mG	  Cre-­‐reporter	  by	  ROSA-­‐CreERT2	  in	  a	  transplanted	  Lewis	  Lung	  tumor.	  Note	  the	  close	  overlap	  of	  CD31	  with	  the	  eGFP	  Cre-­‐reporter.	  Red	  cells	  are	  host-­‐derived	  cells	  in	  the	  tumor	  without	  Cre-­‐excision.	  (B)	  Host	  deletion	  of	  aV	  and	  a5	  by	  ROSA-­‐CreERT2	  does	  not	  affect	  the	  growth	  of	  Lewis	  Lung	  tumors.	  	  
NOTE:	  in	  these	  experiments	  host	  deletion	  (by	  Tam)	  was	  performed	  prior	  to	  
tumor	  growth.	  
NOTE:	  could	  show	  images	  of	  the	  same	  mT/mG	  reporter	  with	  the	  aV;a5	  
deletion	  in	  the	  experiment.	  
NOTE:	  should	  confirm	  the	  deletion	  in	  alphaV	  alpha5	  experiment	  	  -­‐ FACs	  of	  eGFP+	  tumor	  cells,	  qPCR	  for	  mRNA	  (aV,	  a5,	  other	  integrins	  a4,	  a9	  
in	  particular?)	  -­‐ IF	  for	  alpha5	  in	  tumor	  sections	  (alphaV	  is	  difficult)	  	   	  
Figure	  3.	  Compensation	  by	  other	  integrins?	  	  From	  qPCR	  analysis	  of	  isolated	  cells	  from	  LL/2	  tumors,	  test	  whether	  other	  integrins	  are	  upregulated	  in	  the	  absence	  of	  aV	  and	  a5?	  	   	  
	  
Figure	  4.	  Endothelial	  deletion	  of	  Fn	  does	  not	  impair	  the	  growth	  of	  primary	  
tumors	  (A&B)	  The	  deletion	  of	  both	  alphaV	  and	  alpha5	  by	  Cdh5-­‐CreERT2	  does	  not	  impair	  the	  growth	  of	  Lewis	  Lung	  transplant	  tumors	  (A)	  or	  RIP-­‐Tag2	  spontaneous	  pancreatic	  tumors	  (B).	  	  	  
NOTE:	  in	  these	  experiments	  host	  deletion	  (by	  Tam)	  was	  performed	  prior	  to	  
tumor	  growth.	  
NOTE:	  could	  show	  images	  of	  the	  same	  mT/mG	  reporter	  with	  the	  Fn	  deletion	  in	  
the	  experiment.	  
NOTE:	  should	  confirm	  the	  deletion	  in	  alphaV	  alpha5	  experiment	  	  -­‐ FACs	  of	  eGFP+	  tumor	  cells,	  qPCR	  for	  mRNA	  -­‐ IF	  for	  Fn	  in	  tumor	  sections	  (other	  basement	  membrane	  proteins	  as	  well?)	  	  	  
	  -­‐ Maybe	  only	  if	  something	  looks	  differential	  in	  RIP-­‐Tag,	  with	  the	  complete	  
deletion	  of	  Fn),	  since	  this	  should	  be	  milder.	  	   	  
	  
Figure	  5.	  Complete	  deletion	  of	  Fn	  impairs	  tumor	  initiation	  but	  not	  final	  size	  (A)	  Immunofluorescent	  staining	  for	  Fn	  in	  13	  week	  RIP-­‐Tag	  tumors	  of	  mice	  with	  and	  without	  Fn	  deletion.	  Note	  the	  absence	  of	  Fn	  staining	  and	  abundant	  CD31	  labeled	  vasculature.	  (B)	  Western	  blot	  of	  equivalent	  protein	  loads	  of	  whole	  blood	  from	  the	  indicated	  genotypes,	  8	  days	  or	  12	  days	  after	  the	  first	  tamoxifen	  treatment,	  or	  with	  no	  tamoxifen	  treatment.	  (C)	  Western	  blot	  of	  equivalent	  protein	  loads	  of	  tumor	  homogenate	  at	  10	  weeks	  (pool	  of	  tumors	  from	  3	  mice)	  or	  12	  weeks	  (single	  large	  tumor).	  (D)	  Results	  of	  quantitative	  PCR,	  showing	  the	  reduction	  in	  the	  level	  of	  Fn	  transcript,	  relative	  to	  18s,	  in	  the	  indicated	  genotypes.	  Single	  Tam	  was	  treated	  only	  in	  the	  first	  week	  with	  Tamoxifen,	  Continuous	  Tam	  was	  treated	  weekly	  throughout.	  (E)	  Number	  of	  islets	  counted	  at	  10-­‐11	  weeks	  in	  the	  indicated	  genotypes.	  (F)	  Total	  pancreatic	  tumor	  mass	  at	  12-­‐13	  weeks	  in	  the	  indicated	  genotypes.	  For	  D,	  E	  and	  F,	  each	  dot	  represents	  a	  single	  animal.	  	  
NOTE:	  should	  clean	  up	  the	  westerns	  here	  (8	  days	  and	  endpoint	  blood	  Fn,	  with	  
no	  Tam	  controls;	  tumor	  Fn	  on	  a	  single	  blot).	  
	  
NOTE:	  should	  re-­‐run	  the	  qPCR,	  these	  results	  do	  not	  seem	  as	  consistent	  as	  I	  
would	  have	  predicted,	  given	  all	  the	  other	  results.	  	  Should	  be	  a	  more	  
consistently	  strong	  reduction.	  	  Also	  now	  have	  more	  samples	  to	  add.	  
	   	  
	  
Figure	  6.	  	  Compensation	  by	  other	  ECM	  proteins	  	  RNA	  -­‐ at	  least,	  run	  panel	  of	  primers	  for	  other	  ECM	  proteins	  in	  Alexandra’s	  signature	  (12	  week	  vs.	  6	  week	  RIP-­‐Tag)	  -­‐ Or	  run	  entire	  250	  gene	  panel	  on	  tumors	  -­‐ this	  would	  not	  detect	  proteins	  produced	  elsewhere	  (fibrinogen)	  and	  deposited	  locally,	  which	  could	  be	  substituting	  in	  some	  way	  for	  Fn	  	  Protein	  -­‐ at	  least,	  run	  IF	  for	  fibrillins	  1&2,	  colIV,	  LTBPs,	  vitronectin,	  laminin	  a4,	  a5,	  b2	  (not	  sure	  if	  good	  antibodies	  exist	  for	  all	  the	  laminins,	  but	  vitronectin,	  ColIV	  and	  Sakai’s	  Fbn1	  and	  2	  and	  LTBP1	  and	  4	  are	  good.	  -­‐ Or	  run	  proteomics	  experiment	  (have	  >5	  and	  5	  late	  stage	  Fn	  deleted	  tumors).	  	  	  
